NASDAQ:ALNY | Revenue | ALNYLAM PHARMACEUTICALS, INC.

Complete source-backed revenue history.

Available history
2008-12-31 to 2026-06-30
Data captured

Historical Revenue

DateRevenue
2026-06-30$1.29B
2025-12-31$1.1B
2025-09-30$1.25B
2025-06-30$773.69M
2025-03-31$594.19M
2024-12-31$593.17M
2024-09-30$500.92M
2024-06-30$659.83M
2024-03-31$494.33M
2023-12-31$439.72M
2023-09-30$750.53M
2023-06-30$318.75M
2023-03-31$319.29M
2022-12-31$335.04M
2022-09-30$264.31M
2022-06-30$224.82M
2022-03-31$213.26M
2021-12-31$258.54M
2021-09-30$187.63M
2021-06-30$220.55M
2021-03-31$177.57M
2020-12-31$163.56M
2020-09-30$125.85M
2020-06-30$103.96M
2020-03-31$99.48M
2019-12-31$71.68M
2019-09-30$70.06M
2019-06-30$44.71M
2019-03-31$33.29M
2018-12-31$21.03M
2018-09-30$2.07M
2018-06-30$29.91M
2018-03-31$21.9M
2017-12-31$37.92M
2017-09-30$17.1M
2017-06-30$15.93M
2011-03-31$20.9M
2010-12-31$21.19M
2010-09-30$27.67M
2010-06-30$26.62M
2010-03-31$24.56M
2009-12-31$26.63M
2009-09-30$24.25M
2009-06-30$24.6M

Annual Revenue

DateRevenue
2025-12-31$3.71B
2024-12-31$2.25B
2023-12-31$1.83B
2022-12-31$1.04B
2021-12-31$844.29M
2020-12-31$492.85M
2019-12-31$219.75M
2018-12-31$74.91M
2017-12-31$89.91M
2016-12-31$47.16M
2010-12-31$100.04M
2009-12-31$100.53M
2008-12-31$96.16M